Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Synclayer Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Synclayer şirketinin toplam hissedar öz sermayesi ¥5.8B ve toplam borcu ¥2.4B olup, bu da borç-öz sermaye oranını 41% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ¥10.8B ve ¥5.0B dir. Synclayer 'in FAVÖK'ü ¥545.0M faiz karşılama oranı -272.5 dur. Şirketin ¥1.3B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

41.0%

Borç/özkaynak oranı

JP¥2.36b

Borç

Faiz karşılama oranı	-272.5x
Nakit	JP¥1.34b
Eşitlik	JP¥5.77b
Toplam yükümlülükler	JP¥5.03b
Toplam varlıklar	JP¥10.80b

Son finansal sağlık güncellemeleri

Is Synclayer (TSE:1724) A Risky Investment?

Aug 05

Is Synclayer (TYO:1724) Using Too Much Debt?

Feb 04

Recent updates

Does Synclayer's (TYO:1724) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 22

Is Synclayer (TYO:1724) Using Too Much Debt?

Feb 04

Will Synclayer's (TYO:1724) Growth In ROCE Persist?

Jan 14

Be Sure To Check Out Synclayer Inc. (TYO:1724) Before It Goes Ex-Dividend

Dec 24

Is Synclayer Inc. (TYO:1724) A Smart Pick For Income Investors?

Dec 03

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: 1724 'nin kısa vadeli varlıkları ( ¥7.0B ) kısa vadeli yükümlülüklerini ( ¥4.2B ) aşıyor.

Uzun Vadeli Yükümlülükler: 1724 şirketinin kısa vadeli varlıkları ( ¥7.0B ) uzun vadeli yükümlülüklerini ( ¥854.0M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: 1724 'nin net borç/öz sermaye oranı ( 17.8% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: 1724 'nin borç/öz sermaye oranı son 5 yılda 108.7% seviyesinden 41% seviyesine düştü.

Borç Kapsamı: 1724 'nin işletme nakit akışı negatif olduğundan borçlar iyi karşılanamıyor.

Faiz Kapsamı: 1724 ödediğinden daha fazla faiz kazandırıyor, dolayısıyla faiz ödemelerinin karşılanması bir sorun teşkil etmiyor.

Synclayer Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Synclayer (TSE:1724) A Risky Investment?

Is Synclayer (TYO:1724) Using Too Much Debt?

Recent updates

Is Synclayer (TSE:1724) A Risky Investment?

Investor sentiment deteriorates as stock falls 20%

Upcoming dividend of JP¥8.00 per share

First quarter 2024 earnings released: EPS: JP¥29.08 (vs JP¥12.08 in 1Q 2023)

Synclayer Inc. to Report Q2, 2024 Results on Aug 09, 2024

Full year 2023 earnings released: EPS: JP¥93.32 (vs JP¥63.54 in FY 2022)

Synclayer Inc., Annual General Meeting, Mar 28, 2024

Synclayer Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024

Upcoming dividend of JP¥11.00 per share at 2.7% yield

Third quarter 2023 earnings released: EPS: JP¥16.15 (vs JP¥15.53 in 3Q 2022)

Synclayer Inc. to Report Q3, 2023 Results on Nov 14, 2023

Second quarter 2023 earnings released: EPS: JP¥9.27 (vs JP¥19.47 loss in 2Q 2022)

Synclayer Inc. to Report Q2, 2023 Results on Aug 10, 2023

Upcoming dividend of JP¥6.00 per share at 3.4% yield

First quarter 2023 earnings released: EPS: JP¥12.08 (vs JP¥47.46 in 1Q 2022)

Full year 2022 earnings released: EPS: JP¥63.54 (vs JP¥225 in FY 2021)

Synclayer Inc. to Report Fiscal Year 2022 Results on Feb 14, 2023

Upcoming dividend of JP¥11.00 per share

No independent directors

Third quarter 2022 earnings released: EPS: JP¥15.53 (vs JP¥39.56 in 3Q 2021)

Synclayer Inc. to Report Q3, 2022 Results on Nov 10, 2022

Second quarter 2022 earnings released: JP¥19.47 loss per share (vs JP¥21.67 profit in 2Q 2021)

Synclayer Inc. to Report Q2, 2022 Results on Aug 10, 2022

Upcoming dividend of JP¥6.00 per share

First quarter 2022 earnings released: EPS: JP¥47.46 (vs JP¥134 in 1Q 2021)

Now 20% undervalued after recent price drop

Investor sentiment improved over the past week

No independent directors

Now 22% undervalued after recent price drop

Synclayer Inc. to Report Q1, 2022 Results on May 12, 2022

Synclayer Inc., Annual General Meeting, Mar 30, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of JP¥11.00 per share

Third quarter 2021 earnings released: EPS JP¥39.55 (vs JP¥18.49 in 3Q 2020)

Investor sentiment improved over the past week

Synclayer Inc. announced that it has received ¥5.2143 million in funding from SMBC Nikko Securities Inc., Investment Arm

Synclayer Inc. announced that it expects to receive ¥5.2143 million in funding from SMBC Nikko Securities Inc., Investment Arm

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS JP¥21.67 (vs JP¥13.64 in 2Q 2020)

Upcoming dividend of JP¥4.00 per share

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS JP¥134 (vs JP¥57.20 in 1Q 2020)

Investor sentiment improved over the past week

We Like These Underlying Return On Capital Trends At Synclayer (TYO:1724)

Full year 2020 earnings released: EPS JP¥144 (vs JP¥229 in FY 2019)

Is It Worth Buying Synclayer Inc. (TYO:1724) For Its 1.3% Dividend Yield?

New 90-day low: JP¥753

Does Synclayer's (TYO:1724) Statutory Profit Adequately Reflect Its Underlying Profit?

Full year 2020 earnings released: EPS JP¥144 (vs JP¥229 in FY 2019)

Is Synclayer (TYO:1724) Using Too Much Debt?

Will Synclayer's (TYO:1724) Growth In ROCE Persist?

Synclayer Inc. to Report Fiscal Year 2020 Results on Feb 12, 2021

Be Sure To Check Out Synclayer Inc. (TYO:1724) Before It Goes Ex-Dividend

Upcoming Dividend of JP¥6.00 Per Share

New 90-day low: JP¥774

Is Synclayer Inc. (TYO:1724) A Smart Pick For Income Investors?

Third quarter 2020 earnings released: EPS JP¥18.48

Synclayer Inc. to Report Q3, 2020 Results on Nov 12, 2020

New 90-day high: JP¥988

MAS Buddy Co., Ltd acquired 23.95% in Synclayer Inc. (JASDAQ:1724) from Masahiro Yamaguchi.

First half earnings released

Earnings released

New 90-day low - JP¥743

Synclayer Inc. to Report Q2, 2020 Results on Aug 07, 2020

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin